Cause and duration of heart failure may impact on the response to sacubitril/valsartan in patients with heart failure and reduced ejection fraction

被引：0
|
作者：
Mandal, Amit K. J. [1 ]
Missouris, Constantinos G. [1 ,2 ]
机构：
[1] Frimley Hlth NHS Fdn Trust, Dept Cardiol, Wexham Pk Hosp, Slough, Berks, England
[2] Univ Cyprus, Dept Cardiol, Sch Med, Nicosia, Cyprus
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2021年 / 22卷 / 03期
关键词：
D O I：
10.2459/JCM.0000000000001111
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [31] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
  • [32] Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF)
    Nowak, Bernd
    Geiss, Ernst
    Boehm, Michael
    Weil, Joachim
    Boer, Jana
    KARDIOLOGIE, 2023, : 44 - 48
  • [33] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Khan, Muhammad Nauman
    Soomro, Najia Aslam
    Naseeb, Khalid
    Bhatti, Usman Hanif
    Rauf, Rubina
    Balouch, Iram Jehan
    Moazzam, Ali
    Bashir, Sonia
    Ashraf, Tariq
    Karim, Musa
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [34] Sacubitril/valsartan reduces ventrucular arrhythmias in heart failure with reduced ejection fraction
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N26 - N26
  • [35] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
  • [36] Sacubitril/valsartan and low blood pressure in heart failure with reduced ejection fraction
    Bruno, Rosa Maria
    Taddei, Stefano
    EUROPEAN HEART JOURNAL, 2017, 38 (15) : 1144 - 1146
  • [37] Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction
    Greene, Stephen J.
    Fonarow, Gregg C.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2994 - 2997
  • [38] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Muhammad Nauman Khan
    Najia Aslam Soomro
    Khalid Naseeb
    Usman Hanif Bhatti
    Rubina Rauf
    Iram Jehan Balouch
    Ali Moazzam
    Sonia Bashir
    Tariq Ashraf
    Musa Karim
    BMC Cardiovascular Disorders, 23
  • [39] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Liu, Rex C.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 473 - 482
  • [40] Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    Butt, Jawad H.
    Dewan, Pooja
    Jhund, Pardeep S.
    Anand, Inder S.
    Atar, Dan
    Ge, Junbo
    Desai, Akshay S.
    Echeverria, Luis E.
    Kober, Lars
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Rouleau, Jean L.
    Sim, David
    Van Veldhuisen, Dirk J.
    Vrtovec, Bojan
    Zannad, Faiez
    Zile, Michael R.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Solomon, Scott D.
    McMurray, John J., V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : 1130 - 1143
12345